← The Pan-liver Network Theory: From Traditional Chinese Medicine To Western Medicine Editorial: COVID-19 Mechanisms On Cardio-vascular Dysfunction: From Membrane Receptors To Immune Response →
First Case Report Of A Novel KIF13A-ALK Fusion In A Lung Adenocarcinoma Patient And Response To Alectinib With A 4-year Follow-up
Here is one of the pictures featuring the First case report of a novel KIF13A-ALK fusion in a lung adenocarcinoma patient and response to alectinib with a 4-year follow-up. Numerous images associated with the First case report of a novel KIF13A-ALK fusion in a lung adenocarcinoma patient and response to alectinib with a 4-year follow-up can be utilized as your reference point. Below, you'll find some additional pictures related to the First case report of a novel KIF13A-ALK fusion in a lung adenocarcinoma patient and response to alectinib with a 4-year follow-up.
Title: Frontiers | first case report of a novel kif13a-alk fusion in a lungFrontiers | first case report of a novel kif13a-alk fusion in a lung.
Title: Figure 1 from a novel slc8a1-alk fusion in lung adenocarcinoma confersFigure 1 from a novel slc8a1-alk fusion in lung adenocarcinoma confers.
Title: Frontiers | first case report of a novel kif13a-alk fusion in a lungFrontiers | first case report of a novel kif13a-alk fusion in a lung.
